Thus, the collective findings of these investigations indicate that MSLN-CAR NK cells may be effectively employed to eliminate tumor cells, delay ovarian cancer development in vivo and in vitro, and extend the survival of tumor bearing mice. The gene discussed is MSLN; the disease is ovarian cancer.